SPL 2.11% 9.3¢ starpharma holdings limited

Astra Zeneca Quarterly, page-31

  1. 3,255 Posts.
    lightbulb Created with Sketch. 608
    I am OK with 2024 as its a major study but I would expect milestone targets and payments to SPL along the way? And that these milestones/values are shared and not 'commercially restricted' in some way!
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.